 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Architecture & Engineering
Subscriber content preview
December 20, 2002
Corixa ready to market cancer drug
By SAM BENNETT
Journal Staff Reporter
Journal Staff Reporter
Every other week, the Daily Journal of Commerce compiles analysts' recommendations on local stocks.
Stock prices reflect Thursday's close. The Dow dipped 83 points to close at 8,365, while the Nasdaq lost 7 points to close at 1,354. The S&P 500 gave up 7 to close at 884.
. . .
To read this story in full login or purchase a subscription.
Previous columns:
- Infrastructure, server growth helps Avocent, 12-06-2002
- Alaska's flight plan: higher profits, 11-22-2002
- SonoSite growth looks promising, 11-08-2002
- Rate improvements boost Safeco profits, 10-25-2002
- Columbia carves profitable niche, 10-04-2002
- Nike leaps with international sales, 09-20-2002
- Nautilus shows strength in earnings, 09-06-2002
- Cray's DOE deal improves outlook, 08-23-2002